Taking a low-dose daily aspirin long-term may reduce the risk of developing or dying from colorectal cancer by revving the body's immune response to cancer cells, according to a new study.

The findings may offer a complementary mechanism for preventing the development and progression of various cancers.

New research suggests that low dose aspirin may help enhance your immune system and lower your risk of colorectal cancer.

A new study published by Wiley online in CANCER revealed that long-term daily use of aspirin can aid in preventing the development and progression of colorectal cancer. The study suggested

Taking aspirin may help prevent or delay the progression of colorectal cancer, a new study published in the journal 'Cancer' has found. Colorectal cancer rates among people under 50 are going up by 2% each year,

Researchers say daily aspirin use can help prevent the development of colorectal cancer as well as slow disease progress. However, experts note there are some potential serious side effects of taking the pain medication every day.

Now, researchers think they understand how aspirin acts against colon cancer, a new study says. Aspirin appears to boost aspects of the body's immune response against cancer cells, according to findings published Monday in the journal Cancer.